Brazil Clears Sanofi's $635M Medley Pharma Buy
Brazil's antitrust enforcer has given its blessing to Sanofi-Aventis SA's €500 million ($635 million) acquisition of Medley Pharmaceuticals Ltd., provided the Brazilian drug company gives up rights to three of its...To view the full article, register now.
Already a subscriber? Click here to view full article